Teva statement following new york jury ruling in opioids trial

Parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries, ltd. (nyse and tase: teva) strongly disagrees with today's outcome and will prepare for a swift appeal as well as continue to pursue a mistrial. in ny, the plaintiffs presented no evidence of medically unnecessary prescriptions, suspicious or diverted orders, no evidence of oversupply by the defendants – or any indication of what volumes were appropriate – and no causal relationship betw
TEVA Ratings Summary
TEVA Quant Ranking